Latent · Series A

Clinical AI that automates prior authorization and medication access

Amount

$80M

Round

Series A

Valuation

—

Announced

Mar 2026

Investors

Lead investor

Participating investors

Transformation Capital Lead

General Catalyst Conviction McKesson Ventures